News

McKnight's Long-Term Care News2h
Older adults gain new COVID vaccine option as FDA approves protein-based shot
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
STAT1d
Pharmalittle: We’re reading about Regeneron buying 23andMe, the Novavax Covid shot, and more
The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...